Lantern Pharma Inc.
LTRN
$2.51
$0.4521.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -23.78% | 20.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.38% | -6.49% | |||
| Operating Income | 3.38% | 6.49% | |||
| Income Before Tax | 2.47% | 3.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.47% | 3.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.47% | 3.55% | |||
| EBIT | 3.38% | 6.49% | |||
| EBITDA | 3.38% | 6.49% | |||
| EPS Basic | 5.58% | 3.98% | |||
| Normalized Basic EPS | 5.73% | 3.98% | |||
| EPS Diluted | 5.58% | 3.98% | |||
| Normalized Diluted EPS | 5.73% | 3.98% | |||
| Average Basic Shares Outstanding | -- | 0.45% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||